Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ⅱ Non-randomized Multicenter Controlled Trial About Effect of Remnant Ablation Therapy on the Recurrence in Low-risk Differentiated Thyroid Cancer Patients

NCT02418247 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT02418247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02418247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ⅱ Non-randomized Multicenter Controlled Trial About Effect of Remnant Ablation Therapy on the Recurrence in Low-risk Differentiated Thyroid Cancer Patients
Lead sponsor
National Cancer Center, Korea
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 31, 2013
Completion date
December 31, 2020
Enrollment
556 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid neoplasms